Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SCN9A mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of SCN9A mRNA | decreases expression | 20106945
|
C546612 |
brevetoxin 3 |
brevetoxin 3 binds to SCN9A protein | affects binding | 19486905
|
D002118 |
Calcium |
[Lithium Chloride results in increased expression of SCN9A protein] which results in increased uptake of Calcium | increases expression|increases uptake | 19486905
|
D002220 |
Carbamazepine |
SCN9A gene mutant form affects the susceptibility to Carbamazepine | affects response to substance | 17145499
|
D002395 |
Catecholamines |
[Lithium Chloride results in increased expression of SCN9A protein] which results in increased secretion of Catecholamines | increases expression|increases secretion | 19486905
|
D000431 |
Ethanol |
[Fish Oils co-treated with Ethanol] results in increased expression of SCN9A mRNA | affects cotreatment|increases expression | 17347304
|
D005395 |
Fish Oils |
[Fish Oils co-treated with Ethanol] results in increased expression of SCN9A mRNA | affects cotreatment|increases expression | 17347304
|
D018021 |
Lithium Chloride |
[Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of SCN9A mRNA | decreases activity|increases expression | 19486905
|
D018021 |
Lithium Chloride |
Lithium Chloride results in increased expression of SCN9A mRNA | increases expression | 19486905
|
D018021 |
Lithium Chloride |
Lithium Chloride results in increased expression of SCN9A protein | increases expression | 19486905
|
D018021 |
Lithium Chloride |
[Lithium Chloride results in increased expression of SCN9A protein] which results in increased secretion of Catecholamines | increases expression|increases secretion | 19486905
|
D018021 |
Lithium Chloride |
[Lithium Chloride results in increased expression of SCN9A protein] which results in increased uptake of Calcium | increases expression|increases uptake | 19486905
|
D018021 |
Lithium Chloride |
[Lithium Chloride results in increased expression of SCN9A protein] which results in increased uptake of Sodium | increases expression|increases uptake | 19486905
|
D012530 |
Saxitoxin |
Saxitoxin binds to SCN9A protein | affects binding | 19486905
|
D012643 |
Selenium |
Selenium results in increased expression of SCN9A mRNA | increases expression | 18583539
|
D012964 |
Sodium |
[Lithium Chloride results in increased expression of SCN9A protein] which results in increased uptake of Sodium | increases expression|increases uptake | 19486905
|
D012964 |
Sodium |
SCN9A protein results in increased transport of Sodium | increases transport | 16020462
|
D012964 |
Sodium |
Tetrodotoxin inhibits the reaction [SCN9A protein results in increased transport of Sodium] | decreases reaction|increases transport | 16020462
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of SCN9A mRNA | decreases expression | 20106945
|
D013779 |
Tetrodotoxin |
Tetrodotoxin inhibits the reaction [SCN9A protein results in increased transport of Sodium] | decreases reaction|increases transport | 16020462
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of SCN9A mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Carbamazepine |
20.87 | 8986270 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
20.87 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
20.87 | 11752688 15322242 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
20.87 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.96 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
10.64 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
10.64 | 11192467 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
1.99 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.67 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.43 | 16835633 |
MESH:D000303 |
Adrenal Cortex Diseases |
|
Catecholamines |
7.38 | 6895166 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
5.38 | 15451040 15451039 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.30 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.86 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
9.06 | 11141031 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
9.06 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.12 | 19183758 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 15238991 17507914 20603192 17688650 18985861 18316065 18940202 18177632 19460635 18558336 19232924 18396377 17157402 16609825 18775368 |
MESH:D001714 |
Bipolar Disorder |
|
Carbamazepine |
7.59 | 20046352 17594078 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
7.59 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.07 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.08 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.08 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.89 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.89 | 20435547 |
MESH:D002056 |
Burns |
|
Ethanol |
4.69 | 16374292 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
2.40 | 18788625 15763234 15289165 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.06 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
6.89 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.89 | 16120746 18850075 18670907 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.72 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.60 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
5.99 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.99 | 8697196 12621046 15668235 16354765 15340226 |
MESH:D003092 |
Colitis |
|
Selenium |
3.82 | 17936198 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Carbamazepine |
5.50 | 9014606 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
5.50 | 19302082 15451040 11873399 11198716 10194807 15513904 15451039 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.50 | 20055451 15322242 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
5.50 | 17688650 16575769 8888407 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
OMIM:607208 |
DRAVET SYNDROME |
|
Carbamazepine |
5.49 | 11748493 |
MESH:D004342 |
Drug Hypersensitivity |
|
Carbamazepine |
4.42 | 16538176 16538175 15057820 20216337 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbamazepine |
12.14 | 17465707 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
12.14 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
12.14 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
12.14 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
12.14 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Carbamazepine |
8.47 | 20216337 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.47 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.08 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.41 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.96 | 16714409 18230668 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Carbamazepine |
4.77 | 17654737 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.05 | 9294722 10568697 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Carbamazepine |
5.29 | 16538176 18855540 19915237 16415921 20485159 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Carbamazepine |
11.34 | 17275665 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
11.34 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Carbamazepine |
10.59 | 17116037 15008574 16628512 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
10.59 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Carbamazepine |
7.12 | 17465707 17178248 18234410 20417680 19700373 7988514 9014606 19620853 19439326 821787 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
7.12 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.61 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Carbamazepine |
11.85 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
11.85 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Carbamazepine |
11.06 | 3659116 15276670 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
11.06 | 3659116 |
MESH:D004916 |
Erythromelalgia |
marker/mechanism |
|
| 17145499 19549232 |
MESH:D004916 |
Erythromelalgia |
|
Carbamazepine |
5.77 | 19549232 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.62 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
4.62 | 16704527 |
MESH:D005076 |
Exanthema |
|
Carbamazepine |
5.52 | 20485159 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
13.58 | 19236843 18620774 16409862 |
MESH:D005234 |
Fatty Liver |
|
Fish Oils |
13.58 | 18620774 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
13.58 | 14986274 19224547 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.73 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
5.35 | 15451040 16946407 10194807 15513904 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.95 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.17 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.99 | 20067830 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.76 | 15046732 |
OMIM:604403 |
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2 |
marker/mechanism |
|
| |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.49 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.49 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.09 | 17162251 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.93 | 16120746 15340226 12621046 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.92 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Lithium Chloride |
13.24 | 19797860 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
13.24 | 16354765 8697196 18606429 15340226 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
3.74 | 18783367 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Carbamazepine |
4.75 | 10459572 |
MESH:D006949 |
Hyperlipidemias |
|
Fish Oils |
4.79 | 15752949 |
MESH:D006965 |
Hyperplasia |
|
Carbamazepine |
5.25 | 18773962 |
MESH:D006968 |
Hypersensitivity, Delayed |
|
Fish Oils |
5.57 | 11484837 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.91 | 18670907 18850075 |
OMIM:243000 |
INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE |
marker/mechanism |
|
| |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.87 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
4.26 | 16624496 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
10.22 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.22 | 16580747 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.91 | 16518626 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
5.11 | 16316344 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
4.25 | 15451040 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.15 | 16294345 17596541 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.83 | 17676605 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
3.39 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
5.15 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
2.50 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.50 | 12878042 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.69 | 17347304 17207112 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.36 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.36 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.12 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.32 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.19 | 20464547 18520028 20064080 18816296 17053015 20869020 6695378 20135361 18569708 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.19 | 19555203 11884234 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Carbamazepine |
3.57 | 16628512 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.78 | 15318939 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
4.22 | 18411066 15451040 |
MESH:D008607 |
Mental Retardation |
|
Carbamazepine |
3.73 | 9014606 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.80 | 15107826 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.21 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.21 | 16381670 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.06 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.17 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.04 | 12213967 |
MESH:D009224 |
Myotonia Congenita |
|
Carbamazepine |
5.52 | 20399394 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.18 | 11141357 |
MESH:D009421 |
Nervous System Malformations |
|
Carbamazepine |
10.05 | 16990009 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.05 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.14 | 16359493 8888407 |
MESH:D010018 |
Osteomalacia |
|
Carbamazepine |
5.52 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.80 | 17882678 |
MESH:D010146 |
Pain |
|
Carbamazepine |
4.06 | 15215642 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
2.98 | 12384795 |
MESH:D010267 |
Parapsoriasis |
|
Carbamazepine |
5.74 | 16538176 |
OMIM:167400 |
PAROXYSMAL EXTREME PAIN DISORDER |
marker/mechanism |
|
| 17145499 17679678 |
OMIM:167400 |
PAROXYSMAL EXTREME PAIN DISORDER |
|
Carbamazepine |
5.97 | 17679678 17145499 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.95 | 15087411 |
MESH:D011141 |
Polyuria |
|
Lithium Chloride |
6.05 | 19692487 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D011248 |
Pregnancy Complications |
|
Carbamazepine |
5.19 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Carbamazepine |
16.68 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
16.68 | 11896295 11222880 11118676 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
16.68 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.97 | 17292933 |
MESH:D019310 |
Pseudolymphoma |
|
Carbamazepine |
12.81 | 12752131 9591791 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
12.81 | 12752131 11422049 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.21 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Carbamazepine |
10.19 | 15946322 9046859 19414003 9844417 16938433 16876388 16180713 |
MESH:D012640 |
Seizures |
|
Ethanol |
10.19 | 9754883 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
10.19 | 16876388 1511512 11738929 17978042 15475178 11044598 14763951 3137016 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.51 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.51 | 16192470 |
MESH:D012893 |
Sleep Disorders |
|
Carbamazepine |
5.17 | 19414003 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.80 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.60 | 12833885 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Carbamazepine |
5.25 | 15057820 18855540 19915237 16415921 16538176 20485159 19694795 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.54 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
2.54 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.56 | 16755016 9562338 17918041 11906479 17189318 9211565 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
4.28 | 9754883 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.30 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.57 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.19 | 17053015 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.68 | 8888407 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |